Clinical Trials Browser

Enrolling by invitation × Bevacizumab × Clear all

NCT07359404 2026-01-22

Sacituzumab Govitecan Plus Bevacizumab in Metastatic TNBC

Phase 2 Enrolling by invitation

Advanced Breast Cancer

NCT06487715 2024-07-05

Safety and Efficacy of Systemic Chemotherapy Plus PD-1 Inhibitor in Combination With Bevacizumab in Gastric Cancer With Peritoneal Metastasis

Phase 2 Enrolling by invitation

Gastrointestinal

Gastric Cancer Peritoneal Metastases